Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:37:11 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



News for U:MYNZ from 2023-05-04 to 2024-05-03 - 44 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-25 09:29U:MYNZNews ReleaseMainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
2024-04-09 08:01U:MYNZNews ReleaseMainz Biomed Reports Full Year 2023 Financial Results
2024-03-19 08:01U:MYNZNews ReleaseMainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
2024-03-18 08:01U:MYNZNews ReleaseMainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
2024-03-12 08:01U:MYNZNews ReleaseMainz Biomed Presents ColoAlert(TM) at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
2024-03-05 08:01U:MYNZNews ReleaseMainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
2024-02-27 08:01U:MYNZNews ReleaseMainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
2024-02-22 08:01U:MYNZNews ReleaseMainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert ‚ ®
2024-02-21 08:01U:MYNZNews ReleaseMainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert ‚ ® in Italy
2024-02-06 08:01U:MYNZNews ReleaseMainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
2024-01-11 08:01U:MYNZNews ReleaseMainz Biomed and TestDNA Drive CRC Innovation at the 10th Gda … „sk Gastroenterology Symposium
2024-01-09 08:01U:MYNZNews ReleaseMainz Biomed Provides Year-End Corporate Review 2023
2023-12-19 08:01U:MYNZNews ReleaseMainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
2023-12-12 08:01U:MYNZNews ReleaseMainz Biomed Showcases ColoAlert ‚ ® at Two Prominent Gastroenterology Conferences in Poland
2023-12-05 09:02U:MYNZNews ReleaseMainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
2023-11-29 08:01U:MYNZNews ReleaseMainz Biomed ¢ € ™s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
2023-11-20 08:01U:MYNZNews ReleaseMainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
2023-11-16 08:01U:MYNZNews ReleaseMainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2023-11-15 09:02U:MYNZNews ReleaseMainz Biomed Announces Closing of $5.0 million Registered Direct Offering
2023-11-13 09:00U:MYNZNews ReleaseMainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
2023-11-09 08:01U:MYNZNews ReleaseMainz Biomed Partners with Liquid Biosciences ‚  to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
2023-11-07 08:01U:MYNZNews ReleaseMainz Biomed to Showcase ColoAlert ‚ ® at Leading Global Healthcare Event, MEDICA
2023-10-31 08:01U:MYNZNews ReleaseMainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Z ƒ ¶ller-Kipper
2023-10-26 08:01U:MYNZNews ReleaseMainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
2023-10-18 08:01U:MYNZNews ReleaseMainz Biomed Presents Groundbreaking Results of ColoFuture Study
2023-10-11 08:01U:MYNZNews ReleaseMainz Biomed to Showcase ColoAlert ‚ ® at UEG Week 2023 in Copenhagen, Denmark
2023-10-05 08:01U:MYNZNews ReleaseMainz Biomed to Attend the JonesTrading 2023 Healthcare Summit ‚  
2023-10-04 08:01U:MYNZNews ReleaseMainz Biomed Announces Live Launch of ColoAlert ‚ ® with Bioclinica in Romania
2023-09-27 08:01U:MYNZNews ReleaseMainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
2023-09-20 03:01U:MYNZNews ReleaseMainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference ‚  
2023-09-13 03:01U:MYNZNews ReleaseMainz Biomed ¢ € ™s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%
2023-09-05 03:01U:MYNZNews ReleaseMainz Biomed Announces Strategic Partnership with ƒ „rztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
2023-08-29 03:01U:MYNZNews ReleaseMainz Biomed to Present at the H.C. Wainwright Global Investment Conference
2023-08-22 03:01U:MYNZNews ReleaseMainz Biomed Announces Live Launch of ColoAlert ‚ ® with testDNA Laboratory in Poland
2023-08-15 03:01U:MYNZNews ReleaseMainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
2023-08-01 03:01U:MYNZNews ReleaseMainz Biomed Announces Live Launch of ColoAlert ‚ ® with Marylebone Laboratory in the United Kingdom
2023-07-18 03:01U:MYNZNews ReleaseMainz Biomed Announces Collaboration with Fugene Genetics in Israel
2023-06-29 03:02U:MYNZNews ReleaseMainz Biomed Secures up to $50M in New Funding
2023-06-28 03:01U:MYNZNews ReleaseMainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
2023-06-20 03:01U:MYNZNews ReleaseMainz Biomed Expands into Romania Through Partnership with Bioclinica
2023-05-31 03:01U:MYNZNews ReleaseMainz Biomed Expands Commercial Footprint into Poland
2023-05-24 03:01U:MYNZNews ReleaseMainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Z ƒ ¶eller-Kipper
2023-05-16 03:01U:MYNZNews ReleaseMainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
2023-05-10 03:01U:MYNZNews ReleaseMainz Biomed Partners with Microba Life Sciences for the Development of PancAlert